SEARCH

SEARCH BY CITATION

References

  • 1
    Fritsch PO, Ramon RM. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. In: FreedbergIM, EisenAZ, WolffK, AustenKF, GoldsmithLA, KatzSL et al. , eds. Fitzpatrick’s Dermatology in General Medicine, 6th edn. New York: McGraw-Hill, 2003; 548556.
  • 2
    Shirato S, Kagaya F, Suzuki Y, Joukou S. Stevens-Johnson syndrome induced by methazolamide treatment. Arch Ophthalmol 1997; 115(4): 550553.
  • 3
    Sung KH, Jeong Y, Choi HU, Lee SK. Two cases of HLA-B59(+) Stevens-Johnson syndrome-toxic epidermal necrolysis associated with methazolamide treatment. Korean J Dermatol 2005; 43: 561563.
  • 4
    Ha JH, Song JY, Kim HO, Kim JW. A case of Stevens-Johnson syndrome caused by acetazolamide. Korean J Dermatol 2003; 41: 248250.
  • 5
    Valeyrie-Allanore L, Roujeau JC. Epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis). In: FreedbergIM, GoldsmithLA, KatzSL, GilchrestBA, PallerAS, LeffellDJ et al. , eds. Fitzpatrick’s Dermatology in General Medicine, 7th edn. New York: McGraw-Hill, 2007; 349355.
  • 6
    Flach AJ, Smith RE, Fraunfelder FT. Stevens-Johnson syndrome associated with methazolamide treatment reported in two Japanese-American women. Ophthalmology 1995; 102(11): 16771680.
  • 7
    Ahn EY, Lee JB, Lee SC, Won YH. Four cases of Stevens-Johnson syndrome associated with methazolamide treatment. Korean J Dermatol 2000; 38(6): 798801.
  • 8
    Cotter JB. Methazolamide-induced Stevens-Johnson syndrome: a warning! Arch Ophthalmol 1998; 116: 117.
  • 9
    Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: TshujiiK, AizawaM, SasazukiT, eds. HLA 1991. New York, NY: Oxford University Press Inc, 1991; 10651220.
  • 10
    Moon JI, Seo JH, Park CK. Association of HLA type with Stevens – Johnson syndrome induced by methazolamide treatment. J Korean Ophthalmol Soc 2000; 41: 2241.